Doggy drug developer digs up $440M acquisition deal

The company was one of the first biotech animal drug companies — developing drugs for dogs, cats and horses — but it had cut about 60% of its workforce as its commercial strategy produced hairballs.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news